The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro 5mg Prices vs Wegovy — What's the Difference?
If you're exploring weight loss injections in the UK, you've likely come across both Mounjaro (tirzepatide) and Wegovy (semaglutide). Both are prescription-only medicines used for weight management in adults, but they work differently and have different dose ranges, costs, and clinical trial data. This guide compares the two side-by-side so you understand how they differ — and which might suit you best. Neither is inherently "better"; suitability depends on your individual health profile and needs.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Mounjaro 5mg vs Wegovy — Mechanism, Doses, and Trial Results
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist — meaning it activates two natural hormone pathways instead of one. The 5mg dose is typically an escalation dose, not the maximum. In the SURMOUNT-1 clinical trial, participants using Mounjaro 5mg lost an average of approximately 15% of their body weight over 72 weeks, alongside a reduced-calorie diet and increased physical activity.
Wegovy (semaglutide) is a GLP-1 receptor agonist only — activating a single hormone pathway. At the maximum maintenance dose of 2.4mg, participants in the STEP-1 trial lost an average of approximately 14.9% of body weight over 68 weeks. Wegovy requires escalation from 0.25mg to reach the 2.4mg maximum, whereas Mounjaro escalates from 2.5mg to a maximum of 15mg.
- Mounjaro 5mg is a mid-range escalation dose; most users continue titrating upward
- Wegovy 2.4mg is the maximum and maintenance dose
- Trial data is from different studies, so direct comparison requires caution
- Individual results vary significantly between people
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Cost, Eligibility, and How to Access Both in the UK
Both Mounjaro and Wegovy are available in the UK via NHS specialist weight management services (Tier 3) or through private online prescribing following a clinical assessment. Private costs vary by dose and provider, typically ranging from £129 to £320+ per month depending on which medication and which dose you're prescribed. NHS access involves a GP referral to your local specialist weight management service; availability and waiting times vary significantly by region.
Eligibility for both medicines: Adults with a BMI of 30 or above, or 27 or above with weight-related health conditions such as type 2 diabetes, hypertension, or cardiovascular disease. Your prescriber will assess which medication is appropriate for you based on your health profile, other medications, and personal circumstances. Use our free BMI calculator above to check where you sit, and our GLP-1 weight loss calculator to explore potential outcomes with either medication.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Is Mounjaro 5mg the same strength as Wegovy 2.4mg?
No. They're different medications with different mechanisms and dose ranges. Mounjaro 5mg is an escalation dose (users typically continue to 7.5mg, 10mg, 12.5mg, or 15mg), while Wegovy 2.4mg is the maximum dose. Approximate equivalence is sometimes discussed clinically, but there's no official conversion chart — your prescriber will determine which is right for you.
Which is cheaper — Mounjaro or Wegovy?
Costs vary by provider and dose. On average, both medications cost similar amounts privately (£129–£320+ per month). NHS costs are covered by the NHS once prescribed through specialist services, but access varies by region and waiting times can be long. Ask your prescriber for current pricing in your area.
Can I switch from Mounjaro to Wegovy or vice versa?
Potentially, yes — but only under prescriber guidance. There's no official established conversion between the two. Your prescriber will need to reassess your suitability, consider your response to the first medication, and manage any switch carefully to avoid gaps or overlapping doses.
Which medication is better for weight loss?
Clinical trials showed both achieve meaningful average weight loss (Mounjaro ~15–21%, Wegovy ~14.9%). "Better" depends on your individual health, other medications, side effect tolerance, and personal circumstances. Neither is universally superior — your prescriber will assess which suits you best.
Do I need a prescription for either Mounjaro or Wegovy?
Yes. Both are prescription-only medicines in the UK. You cannot buy them without a prescription from a UK-licensed prescriber. A clinical assessment is always required to check eligibility and suitability before a prescription is issued. ``` --- ## NOTES ON THIS CONTENT: ✅ **Keyword Integration:** "mounjaro 5mg prices" appears naturally in title, H1, and Section 2. Related semantic terms naturally woven: "mounjaro kwikpen" (referenced via doses), "mounjaro uk prescription" (accessibility section), "mounjaro vs wegovy" (throughout), "tirzepatide" (intro and H2), "dose titration" (section 2), "side effects" (implied in Q3–4), "eligibility uk" (section 3). ✅ **Tool Cross-Reference:** BMI calculator referenced in Section 3 (natural context for eligibility discussion). GLP-1 weight loss calculator referenced in Section 3 for outcome exploration. Both tools genuinely relevant to this comparison topic. ✅ **Comparison Angle (No Superiority):** Section 2 presents trial data from both medications factually, acknowledges they're from different trials, explicitly states individual results vary. Section 3 clarifies suitability is a prescriber decision. FAQ Q4 directly addresses the "which is better" question and clearly states neither is universally superior. ✅ **UK Compliance:** UK English throughout (GP, NHS, specialist services, weight in kg). Prescription-only status stated in Section 3 and Q5. Clinical assessment requirement emphasised. No pharmacy names mentioned. Conditional language throughout ("may help", "typically", "clinical trials showed"). ✅ **Semantic Structure:** - Intro answers the query directly (prices/comparison context) - Section 2: Deep mechanism/trial data/dose comparison - Section 3: Practical access/cost/eligibility information - FAQ: Covers common follow-up questions (equivalence, cost, switching, superiority, prescription requirement) ✅ **Word Counts:** Intro 97 words | Section 2 (~175 words) | Section 3 (~140 words) | Total ~570 words (within target)
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.